{
 "page": "https://www.cemmeydan.com/research/funding/",
 "markdown": "https://www.cemmeydan.com/research/funding.md",
 "personId": "https://www.cemmeydan.com/#cem-meydan",
 "personName": "Cem Meydan",
 "title": "Research funding and collaborations",
 "description": "Competitively funded research programs to which Dr. Cem Meydan has contributed as co-investigator, key personnel or computational collaborator, with each award's funder, principal investigators, dates, sources and selected outputs.",
 "introduction": [
  "Dr. Cem Meydan has contributed to competitively funded research programs across chromatin biology, blood cancers, cancer disparities, single-cell and spatial multi-omics, viral and microbial genomics, and spaceflight biology. His roles include co-investigator and key personnel, alongside computational research collaborations supported by the NIH, Blood Cancer United (formerly the Leukemia & Lymphoma Society), Cancer Grand Challenges, NASA, and other funders. Together, these programs demonstrate sustained experience in computational research across institutions, disciplines, and translational settings.",
  "These are collaborative awards. Each entry identifies the program’s principal investigators and Dr. Meydan’s role separately. Historical participation predating the Meydan Lab is included for research context.",
  "This is a selected list rather than a complete record of Dr. Meydan’s funded collaborations, and the outputs under each program are representative examples rather than full bibliographies. Further programs and publications may be added as records are reviewed."
 ],
 "researchAreas": [
  {
   "area": "Cancer epigenetics and gene regulation",
   "scope": "BAF/SWI-SNF biology, chromatin looping, B-cell states, and lymphoma therapeutic vulnerabilities."
  },
  {
   "area": "Computational and spatial multi-omics",
   "scope": "integrative genomics, single-cell and spatial analysis, and molecular characterization across tissues and patient cohorts."
  },
  {
   "area": "Infection, microbiome, and virome biology",
   "scope": "computational profiling of microbial and viral communities, host responses, and diagnostic assays."
  },
  {
   "area": "Spaceflight and systems biology",
   "scope": "genomic and epigenomic analyses of molecular responses to spaceflight and environmental stress."
  }
 ],
 "howToRead": [
  "Grant roles follow Dr. Meydan’s professional funding records. Weill Cornell publicly lists his key-personnel role on SAMBAI. Many other public funder records name the award investigators but do not enumerate all co-investigators, key personnel, or scientific contributors.",
  "A program principal investigator leads the named award. Participation in a project, subaward, or shared core does not imply responsibility for the full center budget or award administration.",
  "Multiple cores within one center are grouped under their parent program. Award periods describe the funder’s project dates; individual participation periods are provided separately where they differ. Sources include official award records and publication acknowledgments, with archived copies (Internet Archive Wayback Machine or archive.today) when available.",
  "Selected outputs include only publications coauthored by Dr. Meydan and research resources from the same studies. “Acknowledges” means the paper names that grant in its funding or acknowledgment statement; a paper may acknowledge several awards. Research tools and data portals are attributed to their development teams."
 ],
 "lastReviewed": "2026-10-31",
 "programs": [
  {
   "id": "sambai",
   "title": "SAMBAI: cancer inequities in populations of African descent",
   "group": "Recent and multi-year funded programs",
   "funders": [
    "Cancer Grand Challenges (Cancer Research UK and the U.S. National Cancer Institute)"
   ],
   "program": "SAMBAI — Social, Ancestry, Molecular and Biological Analysis of Inequalities",
   "programType": "International team award (Cancer Grand Challenges)",
   "awardNumbers": [],
   "awardStart": "2024",
   "awardEnd": "2029",
   "awardPeriod": "Funded in 2024. Weill Cornell lists 2024–2029 (Cancer Research UK channel) and 2024–2026 (NCI channel).",
   "principalInvestigators": "Melissa B. Davis (team lead, Morehouse School of Medicine)",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Weill Cornell Medicine faculty profile (VIVO).",
   "roleListedInIndependentRecord": true,
   "summary": "SAMBAI combines large-scale genomic, molecular, environmental, and social data to investigate cancer inequities in populations of African descent. As key personnel, Dr. Meydan contributes computational expertise to molecular characterization and the development of analytical approaches for population-specific cancer research.",
   "notes": [
    "SAMBAI launched in 2024 and is in its data-generation phase; publications from the program are forthcoming.",
    "The two Weill Cornell funding entries are channels within a single SAMBAI research initiative."
   ],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "SAMBAI",
     "publisher": "Cancer Grand Challenges",
     "url": "https://www.cancergrandchallenges.org/sambai",
     "documents": "The team, its lead, year funded and research aims.",
     "archivedCopy": "https://web.archive.org/web/20261030152422/https://www.cancergrandchallenges.org/sambai"
    },
    {
     "title": "Cancer Grand Challenges funding awarded to study cancer inequity",
     "publisher": "Weill Cornell Medicine Newsroom",
     "url": "https://news.weill.cornell.edu/news/2024/03/cancer-grand-challenges-funding-awarded-to-study-cancer-inequity",
     "documents": "Weill Cornell’s participation in the 2024 award.",
     "archivedCopy": "https://web.archive.org/web/20261030152505/https://news.weill.cornell.edu/news/2024/03/cancer-grand-challenges-funding-awarded-to-study-cancer-inequity"
    },
    {
     "title": "Cem Meydan — faculty profile, Research section",
     "publisher": "Weill Cornell VIVO",
     "url": "https://vivo.weill.cornell.edu/display/cwid-cem2009",
     "documents": "Dr. Meydan listed as key personnel on SAMBAI under Cancer Research UK (2024–2029) and the National Cancer Institute (2024–2026).",
     "archivedCopy": "https://web.archive.org/web/20261018135159/https://vivo.weill.cornell.edu/display/cwid-cem2009"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#sambai"
  },
  {
   "id": "lymphoma-spore",
   "title": "Lymphoma SPORE: addressing health disparities in lymphoma",
   "group": "Recent and multi-year funded programs",
   "funders": [
    "NIH / National Cancer Institute"
   ],
   "program": "Lymphoma Outcomes SPORE (Weill Cornell title: SPORE: Addressing Health Disparities in Lymphoma)",
   "programType": "Specialized Program of Research Excellence (U54)",
   "awardNumbers": [
    "U54CA302435"
   ],
   "awardStart": "2025-08-22",
   "awardEnd": "2030-07-31",
   "awardPeriod": "August 2025 – July 2030 (NIH RePORTER; Weill Cornell record).",
   "principalInvestigators": "Christopher R. Flowers (contact PI) and Jean L. Koff, MD Anderson Cancer Center. Weill Cornell subaward: Ari M. Melnick (co-principal investigator; leads Project 1) and Roberta Zappasodi (subaward principal investigator).",
   "meydanRole": "Computational research collaborator",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "The NCI Lymphoma Outcomes SPORE integrates tumor biology, clinical data, and population-level evidence to investigate disparities in lymphoma outcomes. Within the Weill Cornell research effort, Dr. Meydan contributes computational expertise to studies of B-cell states, immune signaling, and chromatin–microenvironment interactions, with an emphasis on biologically informed therapeutic vulnerabilities.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "lmo2",
     "type": "paper",
     "title": "The LMO2–LDB1–TAL1 complex regulates transcription networks in acute myeloid leukemia",
     "year": "2025",
     "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12835595/",
     "acknowledges": "U54CA302435",
     "note": "Coauthored study of the transcriptional networks of acute myeloid leukemia.",
     "archivedCopy": null
    }
   ],
   "components": [
    {
     "title": "Project 1: Precision targeting of therapeutic vulnerabilities specific to African American lymphoma patients.",
     "text": "Led by Ari M. Melnick (NIH RePORTER subproject listing).",
     "sources": []
    }
   ],
   "sources": [
    {
     "title": "Lymphoma Outcomes SPORE, U54CA302435",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/11401426",
     "documents": "Award number, principal investigators, project dates, projects and cores.",
     "archivedCopy": "https://web.archive.org/web/20261030161909/https://reporter.nih.gov/project-details/11401426"
    },
    {
     "title": "SPORE: Addressing Health Disparities in Lymphoma (Weill Cornell subaward)",
     "publisher": "Weill Cornell VIVO",
     "url": "https://vivo.weill.cornell.edu/display/grant-0000074706",
     "documents": "Weill Cornell subaward of U54CA302435, 2025–2030, and its Weill Cornell investigators.",
     "archivedCopy": "https://web.archive.org/web/20261030152615/https://vivo.weill.cornell.edu/display/grant-0000074706"
    },
    {
     "title": "Christopher Flowers, MD",
     "publisher": "MD Anderson Cancer Center",
     "url": "https://faculty.mdanderson.org/profiles/christopher_flowers.html",
     "documents": "The program’s contact principal investigator.",
     "archivedCopy": "https://web.archive.org/web/20261030152649/https://faculty.mdanderson.org/profiles/christopher_flowers.html"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#lymphoma-spore"
  },
  {
   "id": "bcu-scor-chromatin",
   "title": "Epigenetic mechanisms and targeting in hematological malignancy",
   "group": "Recent and multi-year funded programs",
   "funders": [
    "Blood Cancer United (formerly the Leukemia & Lymphoma Society)"
   ],
   "program": "Epigenetic Mechanisms and Targeting in Hematological Malignancy — Specialized Center of Research (SCOR)",
   "programType": "Specialized Center of Research (multi-project center)",
   "awardNumbers": [],
   "awardStart": "2024-10-01",
   "awardEnd": "2029-09-30",
   "awardPeriod": "October 2024 – September 2029 (Blood Cancer United).",
   "principalInvestigators": "Jonathan D. Licht (center principal investigator). Project 1, on chromatin looping in B-cell lymphoma, is led by Ari M. Melnick.",
   "meydanRole": "Computational genomics collaborator",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This Blood Cancer United SCOR investigates epigenetic dysregulation and therapeutic vulnerabilities in hematologic malignancies. Dr. Meydan’s work within the lymphoma chromatin-looping effort applies computational approaches to CTCF, PDS5B, and loop extrusion, linking genome organization with B-cell gene regulation.",
   "notes": [
    "This center continues an earlier Leukemia & Lymphoma Society SCOR led by Dr. Licht (2019–2024, listed under Cancer research and translational programs). The two award cycles are separate entries."
   ],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "Epigenetic Mechanisms and Targeting in Hematological Malignancy",
     "publisher": "Blood Cancer United",
     "url": "https://bloodcancerunited.org/research/award/epigenetic-mechanisms-and-targeting-hematological-malignancy",
     "documents": "Project term, center principal investigator and the five project descriptions, including Project 1 on DNA looping.",
     "archivedCopy": "https://web.archive.org/web/20260119113857/https://bloodcancerunited.org/research/award/epigenetic-mechanisms-and-targeting-hematological-malignancy"
    },
    {
     "title": "Jonathan Licht, MD",
     "publisher": "Blood Cancer United",
     "url": "https://bloodcancerunited.org/award-recipient/jonathan-licht",
     "documents": "Dr. Licht as principal investigator of the SCOR program.",
     "archivedCopy": null
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#bcu-scor-chromatin"
  },
  {
   "id": "vast-virome",
   "title": "VAST Center: Viromes Across Space(s) and Time",
   "group": "Recent and multi-year funded programs",
   "funders": [
    "NIH Common Fund, Human Virome Program (administered by the National Institute on Aging)"
   ],
   "program": "VAST Center: Viromes Across Space(s) and Time — Human Virome Characterization Center",
   "programType": "Multi-institutional research center (U54)",
   "awardNumbers": [
    "U54AG089334"
   ],
   "awardStart": "2025-02-01",
   "awardEnd": "2030-01-31",
   "awardPeriod": "February 2025 – January 2030 (NIH RePORTER).",
   "principalInvestigators": "Michael P. Snyder (contact PI), Ami S. Bhatt and Christopher E. Mason; led from Stanford University.",
   "meydanRole": "Computational and multi-omics collaborator",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "The NIH-funded VAST Center characterizes the human virome across people, body sites, environments, and time using longitudinal samples and molecular profiling. Dr. Meydan contributes computational and multi-omic research expertise to this multi-institutional effort, extending his work at the intersection of microbial genomics and human molecular biology.",
   "notes": [
    "The VAST Center launched in 2025 and is in its initial sample-collection and data-generation phase; center publications are forthcoming. An early coauthored study acknowledging the award is listed below."
   ],
   "selectedOutputs": [
    {
     "id": "pcresol",
     "type": "paper",
     "title": "Systemic elevation of gut-derived p-cresol during one year in space",
     "year": "2026",
     "url": "https://doi.org/10.3389/fphys.2026.1878680",
     "acknowledges": "U54AG089334",
     "note": "Coauthored longitudinal metabolomic study from the NASA Twins Study.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Human Virome Program — Funded Research",
     "publisher": "NIH Common Fund",
     "url": "https://commonfund.nih.gov/humanvirome/fundedresearch",
     "documents": "The VAST Center among the funded Human Virome Characterization Centers, with its principal investigators.",
     "archivedCopy": "https://web.archive.org/web/20261030153432/https://commonfund.nih.gov/humanvirome/fundedresearch"
    },
    {
     "title": "VAST Center, U54AG089334",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/11261126",
     "documents": "Award number, principal investigators, institution and project dates.",
     "archivedCopy": "https://web.archive.org/web/20261030161942/https://reporter.nih.gov/project-details/11261126"
    },
    {
     "title": "Stanford Medicine awarded grant to study viral community in humans",
     "publisher": "Stanford Medicine News Center",
     "url": "https://med.stanford.edu/news/all-news/2025/05/snyder-virome-grant.html",
     "documents": "Center launch (May 2025), aims and principal investigators.",
     "archivedCopy": "https://web.archive.org/web/20261030153541/https://med.stanford.edu/news/all-news/2025/05/snyder-virome-grant.html"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#vast-virome"
  },
  {
   "id": "bcu-scor-immune-niche",
   "title": "The immune niche in the development of hematological malignancies",
   "group": "Recent and multi-year funded programs",
   "funders": [
    "Blood Cancer United (formerly the Leukemia & Lymphoma Society)"
   ],
   "program": "The Immune Niche in the Development of Hematological Malignancies and Implications for Novel Therapy — Specialized Center of Research (SCOR)",
   "programType": "Specialized Center of Research (four projects, three cores)",
   "awardNumbers": [
    "LLS 7029-22 (Weill Cornell subaward for the single-cell core)"
   ],
   "awardStart": "2022-10-01",
   "awardEnd": "2027-09-30",
   "awardPeriod": "October 2022 – September 2027 (Blood Cancer United; Weill Cornell record).",
   "principalInvestigators": "Tak W. Mak (center principal investigator, Princess Margaret Cancer Centre). At Weill Cornell: Christopher E. Mason (core lead and subaward principal investigator) and Ari M. Melnick (Project 2 lead).",
   "meydanRole": "Key personnel, in two components of the same program",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This Blood Cancer United SCOR investigates how the immune and stromal environment shapes hematologic malignancies and creates treatment opportunities. As key personnel in its Weill Cornell components, Dr. Meydan contributes single-cell, spatial, and integrative computational analysis through the informatics core and the diffuse large B-cell lymphoma project.",
   "notes": [
    "The informatics core and the DLBCL project are components of the same SCOR award."
   ],
   "selectedOutputs": [
    {
     "id": "lmo2",
     "type": "paper",
     "title": "The LMO2–LDB1–TAL1 complex regulates transcription networks in acute myeloid leukemia",
     "year": "2025",
     "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12835595/",
     "acknowledges": "LLS 7029-23/22",
     "note": "Coauthored acute myeloid leukemia study; the SCOR is acknowledged under the combined identifier.",
     "archivedCopy": null
    }
   ],
   "components": [
    {
     "title": "Core B / Core 2: Spatial, Single-cell, and Integrative Informatics and Statistics Core.",
     "text": "Led by Christopher E. Mason; Weill Cornell subaward LLS 7029-22.",
     "sources": [
      {
       "title": "Weill Cornell record",
       "publisher": "Weill Cornell VIVO",
       "url": "https://vivo.weill.cornell.edu/display/grant-0000049375",
       "documents": "Core 2 subaward LLS 7029-22, 2022–2027, with Christopher E. Mason as subaward principal investigator."
      }
     ]
    },
    {
     "title": "Project 2: Genetically and epigenetically modified targets in the immune niche of diffuse large B-cell lymphoma.",
     "text": "Led by Ari M. Melnick.",
     "sources": []
    }
   ],
   "sources": [
    {
     "title": "The Immune Niche in the Development of Hematological Malignancies and Implications for Novel Therapy",
     "publisher": "Blood Cancer United",
     "url": "https://bloodcancerunited.org/research/award/immune-niche-development-hematological-malignancies-and-implications-novel-therapy?campaign=813273",
     "documents": "Project term, center principal investigator, and the projects and cores with their leads (Project 2: Ari Melnick; Core B: Christopher Mason).",
     "archivedCopy": null
    },
    {
     "title": "Immune Niche SCOR, Core 2 (LLS 7029-22)",
     "publisher": "Weill Cornell VIVO",
     "url": "https://vivo.weill.cornell.edu/display/grant-0000049375",
     "documents": "The Weill Cornell core subaward, its dates and investigators.",
     "archivedCopy": "https://web.archive.org/web/20261030153616/https://vivo.weill.cornell.edu/display/grant-0000049375"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#bcu-scor-immune-niche"
  },
  {
   "id": "baf-r01",
   "title": "BAF complex deregulation in lymphoma",
   "group": "Recent and multi-year funded programs",
   "funders": [
    "NIH / National Cancer Institute"
   ],
   "program": "BAF complex deregulation in lymphoma",
   "programType": "Research project grant (R01)",
   "awardNumbers": [
    "R01CA266279"
   ],
   "awardStart": "2022-08-02",
   "awardEnd": "2027-07-31",
   "awardPeriod": "August 2022 – July 2027 (NIH RePORTER).",
   "principalInvestigators": "Michael R. Green (contact PI, MD Anderson Cancer Center) and Christopher E. Mason. Weill Cornell subaward: Christopher E. Mason (subaward principal investigator) and Ari M. Melnick (co-principal investigator).",
   "meydanRole": "Co-investigator",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NCI R01 investigates how BAF/SWI-SNF chromatin-remodeling defects contribute to lymphoma development and altered gene regulation. As a co-investigator, Dr. Meydan brings computational epigenomics and cell-state analysis expertise to the collaborative research. Related publications from the participating groups address ARID1A, SWI/SNF, and 3D genome organization.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "baf-ctcf",
     "type": "paper",
     "title": "SWI/SNF complexes shape 3D chromatin architecture through CTCF and cohesin",
     "year": "2026",
     "url": "https://doi.org/10.1038/s41586-026-11197-w",
     "acknowledges": "R01 CA266279",
     "note": "Dr. Meydan is co-first and co-corresponding author and led the computational analyses.",
     "archivedCopy": null
    },
    {
     "id": "arid1a",
     "type": "paper",
     "title": "ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors",
     "year": "2024",
     "url": "https://doi.org/10.1016/j.ccell.2024.02.010",
     "acknowledges": "R01 CA266279",
     "note": "Dr. Meydan is co-first author.",
     "archivedCopy": null
    },
    {
     "id": "smarca4",
     "type": "paper",
     "title": "SMARCA4 is a haploinsufficient B-cell lymphoma tumor suppressor",
     "year": "2024",
     "url": "https://doi.org/10.1016/j.ccell.2024.02.011",
     "acknowledges": "R01CA266279",
     "note": "Coauthored study of SMARCA4 loss in B-cell lymphoma.",
     "archivedCopy": null
    },
    {
     "id": "lmo2",
     "type": "paper",
     "title": "The LMO2–LDB1–TAL1 complex regulates transcription networks in acute myeloid leukemia",
     "year": "2025",
     "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12835595/",
     "acknowledges": "R01CA266279",
     "note": "Coauthored study of the transcriptional networks of acute myeloid leukemia.",
     "archivedCopy": null
    },
    {
     "id": "baf-ctcf-code",
     "type": "resource",
     "title": "Nature 2026 analysis code",
     "year": null,
     "url": "https://github.com/meydan-lab/Nature_2026_BAF_CTCF",
     "acknowledges": null,
     "note": "Analysis code for the coauthored study.",
     "archivedCopy": "https://web.archive.org/web/20261030205432/https://github.com/meydan-lab/Nature_2026_BAF_CTCF"
    },
    {
     "id": "arid1a-patent",
     "type": "resource",
     "title": "ARID1A-related patent application",
     "year": null,
     "url": "https://patents.google.com/patent/WO2025096976A1/en",
     "acknowledges": null,
     "note": "Related invention — named inventor.",
     "archivedCopy": "https://web.archive.org/web/20261030205540/https://patents.google.com/patent/WO2025096976A1/en"
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "BAF complex deregulation in lymphoma, R01CA266279",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/11380634",
     "documents": "Award number, principal investigators, institution and project dates.",
     "archivedCopy": "https://web.archive.org/web/20261030162016/https://reporter.nih.gov/project-details/11380634"
    },
    {
     "title": "BAF complex deregulation in lymphoma (Weill Cornell subaward)",
     "publisher": "Weill Cornell VIVO",
     "url": "https://vivo.weill.cornell.edu/display/grant-0000047100",
     "documents": "Weill Cornell subaward of R01CA266279, 2022–2027, and its Weill Cornell investigators.",
     "archivedCopy": "https://web.archive.org/web/20261019034426/https://vivo.weill.cornell.edu/display/grant-0000047100"
    },
    {
     "title": "Discovery suggests new strategy against follicular lymphoma",
     "publisher": "Weill Cornell Medicine Newsroom",
     "url": "https://news.weill.cornell.edu/news/2024/03/discovery-suggests-new-strategy-against-follicular-lymphoma",
     "documents": "Related ARID1A research from the collaborating laboratories.",
     "archivedCopy": "https://web.archive.org/web/20261030154308/https://news.weill.cornell.edu/news/2024/03/discovery-suggests-new-strategy-against-follicular-lymphoma"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#baf-r01"
  },
  {
   "id": "ebv-r37",
   "title": "Targeting the latency switch in EBV-associated lymphomas",
   "group": "Cancer research and translational programs",
   "funders": [
    "NIH / National Cancer Institute"
   ],
   "program": "Targeting Latency Switch in EBV+ Lymphomas",
   "programType": "MERIT award (R37)",
   "awardNumbers": [
    "R37CA262517"
   ],
   "awardStart": "2022-07-01",
   "awardEnd": "2027-06-30",
   "awardPeriod": "July 2022 – June 2027 (NIH RePORTER). Held at Weill Cornell Medicine through February 2026, then transferred to NYU Grossman School of Medicine.",
   "principalInvestigators": "Lisa Giulino Roth (principal investigator)",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NCI-funded research tests strategies to modify Epstein–Barr virus latency in lymphoma and improve the visibility of malignant cells to immune responses. Dr. Meydan contributed computational research expertise to the program’s investigation of viral gene regulation and epigenetic therapeutic strategies during his Weill Cornell participation.",
   "notes": [
    "Some public records end on February 28, 2026: that date closes the Weill Cornell period of the award. NIH RePORTER lists the continuation at NYU Grossman School of Medicine through June 30, 2027."
   ],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "Targeting Latency Switch in EBV+ Lymphomas, R37CA262517",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/11543791",
     "documents": "Principal investigator, project dates and the 2026 change of institution.",
     "archivedCopy": "https://web.archive.org/web/20261030162051/https://reporter.nih.gov/project-details/11543791"
    },
    {
     "title": "R37CA262517 award detail",
     "publisher": "HHS TAGGS",
     "url": "https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R37CA262517&arg_ProgOfficeCode=110",
     "documents": "Award actions by fiscal year.",
     "archivedCopy": "https://web.archive.org/web/20261030170101/https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R37CA262517&arg_ProgOfficeCode=110"
    },
    {
     "title": "EBV-associated lymphomas",
     "publisher": "Roth Lab, Weill Cornell Medicine",
     "url": "https://rothlab.weill.cornell.edu/research/projects/ebvassociatedlymphomas",
     "documents": "The research project and its aims.",
     "archivedCopy": "https://web.archive.org/web/20261030154716/https://rothlab.weill.cornell.edu/research/projects/ebvassociatedlymphomas"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#ebv-r37"
  },
  {
   "id": "chromatin-architecture-p01",
   "title": "Chromatin architecture and cancer progression",
   "group": "Cancer research and translational programs",
   "funders": [
    "NIH / National Cancer Institute"
   ],
   "program": "The Impact of Changes in Chromatin Architecture on Cancer Phenotypes and Tumor Progression",
   "programType": "Program project grant (P01)",
   "awardNumbers": [
    "P01CA229086"
   ],
   "awardStart": "2019-06-12",
   "awardEnd": "2030-03-31",
   "awardPeriod": "Program project from June 2019; renewed, with current project dates through March 2030 (NIH RePORTER).",
   "principalInvestigators": "Jane A. Skok (program principal investigator, NYU Grossman School of Medicine). Project leads in the first cycle included Ari M. Melnick (Project 2, the cohesin complex in myeloid leukemia) and Iannis Aifantis.",
   "meydanRole": "Key personnel",
   "meydanParticipation": "2019–2024 (Dr. Meydan’s records).",
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NCI program examines how changes in 3D chromatin architecture alter gene regulation, cell identity, and cancer progression. Dr. Meydan contributed computational genomics expertise to the collaborative research during the 2019–2024 period of his involvement.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "setd2",
     "type": "paper",
     "title": "SETD2 haploinsufficiency enhances AICDA mutagenesis in B-cell lymphoma",
     "year": "2022",
     "url": "https://doi.org/10.1158/2159-8290.CD-21-1514",
     "acknowledges": "P01 CA229086",
     "note": "Coauthored study of SETD2 loss and AICDA mutagenesis in B-cell lymphoma.",
     "archivedCopy": null
    },
    {
     "id": "smc3",
     "type": "paper",
     "title": "Smc3 dosage regulates B-cell transit through germinal centers",
     "year": "2021",
     "url": "https://doi.org/10.1038/s41590-020-00827-8",
     "acknowledges": "P01 CA229086",
     "note": "Coauthored study of cohesin dosage in germinal-center B cells and lymphomagenesis.",
     "archivedCopy": null
    },
    {
     "id": "ball",
     "type": "paper",
     "title": "Evolution of the epigenetic landscape in childhood B-ALL and drug resistance",
     "year": "2020",
     "url": "https://doi.org/10.1158/0008-5472.CAN-20-1145",
     "acknowledges": "P01 CA229086",
     "note": "Coauthored study of epigenetic evolution and drug resistance in childhood B-ALL.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "The impact of changes in chromatin architecture on cancer phenotypes and tumor progression, P01CA229086",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/11310791",
     "documents": "Program principal investigator, project dates, and projects and cores with their leads.",
     "archivedCopy": "https://web.archive.org/web/20261030162126/https://reporter.nih.gov/project-details/11310791"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#chromatin-architecture-p01"
  },
  {
   "id": "mcl-p01",
   "title": "Mechanism-based targeting of mantle cell lymphoma",
   "group": "Cancer research and translational programs",
   "funders": [
    "NIH / National Cancer Institute"
   ],
   "program": "Mechanism-Based Targeting of Mantle Cell Lymphoma",
   "programType": "Program project grant (P01)",
   "awardNumbers": [
    "P01CA214274"
   ],
   "awardStart": "2018-09-18",
   "awardEnd": "2025-08-31",
   "awardPeriod": "September 2018 – August 2025 (NIH RePORTER).",
   "principalInvestigators": "Selina Y. Chen-Kiang (program principal investigator, Weill Cornell Medicine)",
   "meydanRole": "Key personnel",
   "meydanParticipation": "2018–2024 (Dr. Meydan’s records).",
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NCI program brought together molecular, functional-genomic, and statistical research to define dependencies and therapeutic opportunities in mantle cell lymphoma, including CDK4, FOXO and chromatin remodeling, and PRMT5. Dr. Meydan contributed computational biology expertise as key personnel in this multi-investigator translational research effort.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "prmt5",
     "type": "paper",
     "title": "PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma",
     "year": "2023",
     "url": "https://doi.org/10.1182/blood.2022019419",
     "acknowledges": "P01 CA214274",
     "note": "Coauthored mantle cell lymphoma study.",
     "archivedCopy": null
    },
    {
     "id": "sox11",
     "type": "paper",
     "title": "The novel immunocompetent Eμ-SOX11CCND1 mouse model resembles human mantle cell lymphoma",
     "year": "2025",
     "url": "https://doi.org/10.1158/1078-0432.CCR-25-0534",
     "acknowledges": "P01CA214274",
     "note": "Coauthored study establishing an immunocompetent mantle cell lymphoma mouse model.",
     "archivedCopy": null
    },
    {
     "id": "arid1a",
     "type": "paper",
     "title": "ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors",
     "year": "2024",
     "url": "https://doi.org/10.1016/j.ccell.2024.02.010",
     "acknowledges": "P01 CA214274",
     "note": "Coauthored B-cell lymphoma study; Dr. Meydan is co-first author.",
     "archivedCopy": null
    },
    {
     "id": "crebbp",
     "type": "paper",
     "title": "Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41467-024-47012-1",
     "acknowledges": "P01CA214274",
     "note": "Coauthored lymphoma study.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Mechanism-Based Targeting of Mantle Cell Lymphoma, P01CA214274",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/10478980",
     "documents": "Program principal investigator, project dates, and projects and cores with their leads.",
     "archivedCopy": "https://web.archive.org/web/20261030162204/https://reporter.nih.gov/project-details/10478980"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#mcl-p01"
  },
  {
   "id": "lls-scor-enhancer",
   "title": "Targeting enhancer dysfunction in hematological malignancy",
   "group": "Cancer research and translational programs",
   "funders": [
    "Leukemia & Lymphoma Society (now Blood Cancer United)"
   ],
   "program": "Targeting Enhancer Dysfunction in Hematological Malignancy — Specialized Center of Research (SCOR)",
   "programType": "Specialized Center of Research",
   "awardNumbers": [
    "LLS SCOR 7021-20"
   ],
   "awardStart": "2019-10",
   "awardEnd": "2024-09",
   "awardPeriod": "October 2019 – September 2024 (Dr. Meydan’s records).",
   "principalInvestigators": "Jonathan D. Licht (center principal investigator); collaborators include Ari M. Melnick.",
   "meydanRole": "Key personnel (Core B)",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This LLS Specialized Center of Research investigated enhancer dysfunction and epigenetic mechanisms in blood cancers. As key personnel in Core B, Dr. Meydan contributed computational research expertise to the center’s studies of dysregulated gene expression and therapeutic opportunities.",
   "notes": [
    "This is the award cycle before the 2024–2029 Blood Cancer United SCOR led by Dr. Licht (listed under Recent and multi-year funded programs). They are separate entries."
   ],
   "selectedOutputs": [
    {
     "id": "baf-ctcf",
     "type": "paper",
     "title": "SWI/SNF complexes shape 3D chromatin architecture through CTCF and cohesin",
     "year": "2026",
     "url": "https://doi.org/10.1038/s41586-026-11197-w",
     "acknowledges": "LLS SCOR 7021-20",
     "note": "Dr. Meydan is co-first and co-corresponding author.",
     "archivedCopy": null
    },
    {
     "id": "arid1a",
     "type": "paper",
     "title": "ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors",
     "year": "2024",
     "url": "https://doi.org/10.1016/j.ccell.2024.02.010",
     "acknowledges": "LLS SCOR 7021-20",
     "note": "Dr. Meydan is co-first author.",
     "archivedCopy": null
    },
    {
     "id": "crebbp",
     "type": "paper",
     "title": "Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41467-024-47012-1",
     "acknowledges": "LLS SCOR 7021-20",
     "note": "Coauthored lymphoma study.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Jonathan Licht, MD",
     "publisher": "Blood Cancer United",
     "url": "https://bloodcancerunited.org/award-recipient/jonathan-licht",
     "documents": "Dr. Licht as principal investigator of a continuing LLS SCOR program.",
     "archivedCopy": null
    },
    {
     "title": "SWI/SNF complexes, CTCF and 3D genome organization (Nature, 2026)",
     "publisher": "Nature",
     "url": "https://www.nature.com/articles/s41586-026-11197-w",
     "documents": "Funding statement: Ari Melnick supported by LLS SCOR 7021-20. Dr. Meydan is a co-first and co-corresponding author of the paper.",
     "archivedCopy": "https://web.archive.org/web/20261030155944/https://www.nature.com/articles/s41586-026-11197-w?error=cookies_not_supported&code=c53e4abc-baab-4f61-af91-f335299356f5"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#lls-scor-enhancer"
  },
  {
   "id": "lls-scor-dna-damage",
   "title": "Epigenetics and DNA damage responses in hematologic disorders",
   "group": "Cancer research and translational programs",
   "funders": [
    "Leukemia & Lymphoma Society (now Blood Cancer United)"
   ],
   "program": "Therapeutic Implications of Altered Epigenetics and DNA Damage Responses in Hematologic Disorders — Specialized Center of Research (SCOR)",
   "programType": "Specialized Center of Research",
   "awardNumbers": [
    "LLS 9238-16"
   ],
   "awardStart": "2016",
   "awardEnd": "2022",
   "awardPeriod": "2016–2022 (program period stated by Blood Cancer United).",
   "principalInvestigators": "Tak W. Mak (center principal investigator)",
   "meydanRole": "Key personnel (Core B)",
   "meydanParticipation": "2016–2021 (Dr. Meydan’s records).",
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This LLS SCOR examined the interaction of epigenetic abnormalities and DNA-damage responses in hematologic malignancies. Dr. Meydan contributed to its computational research core as key personnel, building experience across mechanistic cancer epigenomics and multi-investigator therapeutic research. The program preceded the 2022–2027 immune-niche SCOR led by Dr. Mak.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "arid1a",
     "type": "paper",
     "title": "ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors",
     "year": "2024",
     "url": "https://doi.org/10.1016/j.ccell.2024.02.010",
     "acknowledges": "LLS 9238-16",
     "note": "Dr. Meydan is co-first author.",
     "archivedCopy": null
    },
    {
     "id": "soma",
     "type": "paper",
     "title": "The Space Omics and Medical Atlas (SOMA) and international astronaut biobank",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41586-024-07639-y",
     "acknowledges": "LLS 9238-16",
     "note": "Dr. Meydan is co-corresponding author.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "The Immune Niche in the Development of Hematological Malignancies (lay abstract)",
     "publisher": "Blood Cancer United",
     "url": "https://bloodcancerunited.org/research/award/immune-niche-development-hematological-malignancies-and-implications-novel-therapy?campaign=813273",
     "documents": "States that Dr. Mak’s team held a previous LLS SCOR from 2016 to 2022.",
     "archivedCopy": null
    },
    {
     "title": "SOMA Browser — funding acknowledgments",
     "publisher": "Weill Cornell Medicine",
     "url": "https://soma.weill.cornell.edu/apps/SOMA_Browser/",
     "documents": "Lists LLS 9238-16 among the grants acknowledged by the SOMA Browser, whose code and visualizations are by Dr. Meydan.",
     "archivedCopy": "https://web.archive.org/web/20261030155826/https://soma.weill.cornell.edu/apps/SOMA_Browser/"
    },
    {
     "title": "Circulating miRNA spaceflight signature reveals targets for countermeasure development (Cell Reports, 2020)",
     "publisher": "Cell Reports",
     "url": "https://doi.org/10.1016/j.celrep.2020.108448",
     "documents": "A paper coauthored by Dr. Meydan whose funding statement lists “LLS 9238-16, Mak”.",
     "archivedCopy": null
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#lls-scor-dna-damage"
  },
  {
   "id": "lls-scor-2012",
   "title": "Chromatin mechanisms and epigenetic targeting in hematological malignancies",
   "group": "Cancer research and translational programs",
   "funders": [
    "Leukemia & Lymphoma Society (now Blood Cancer United)"
   ],
   "program": "Marshall A. Lichtman Specialized Center of Research (SCOR) led by Jonathan Licht, 2012 award cycle (project title in Dr. Meydan’s records: Chromatin Mechanisms and Epigenetic Targeting in Hematological Malignancies)",
   "programType": "Specialized Center of Research",
   "awardNumbers": [],
   "awardStart": "2012",
   "awardEnd": "2017",
   "awardPeriod": "Five-year award announced by LLS in September 2012.",
   "principalInvestigators": "Jonathan D. Licht (center principal investigator, then at Northwestern University), with co-investigators at Rockefeller University, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center and the University of Michigan.",
   "meydanRole": "Key personnel",
   "meydanParticipation": "2015–2017 (Dr. Meydan’s records).",
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This earlier LLS SCOR brought together investigators studying chromatin regulation and epigenetic targets in leukemia, lymphoma, and myeloma. Dr. Meydan served as key personnel within the Weill Cornell collaboration during the later years of this award cycle.",
   "notes": [
    "Dr. Licht’s SCOR program has been funded in successive award cycles. The 2019–2024 and 2024–2029 cycles are separate entries."
   ],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "Licht receives grant for blood cancer research",
     "publisher": "Northwestern University Feinberg School of Medicine",
     "url": "https://news.feinberg.northwestern.edu/2012/10/09/leukemia_grant/",
     "documents": "The 2012 SCOR award to Dr. Licht, its five-year term and its co-investigator institutions, including Weill Cornell.",
     "archivedCopy": "https://web.archive.org/web/20261030162630/https://news.feinberg.northwestern.edu/2012/10/09/leukemia_grant/"
    },
    {
     "title": "Licht Lab news (reproduces the LLS press release of September 5, 2012)",
     "publisher": "Licht Lab, OpenWetWare",
     "url": "https://openwetware.org/wiki/Licht:Lab_News",
     "documents": "LLS’s announcement of the four 2012 SCOR awards and the scientific aims of Dr. Licht’s center.",
     "archivedCopy": "https://web.archive.org/web/20261030162757/https://openwetware.org/wiki/Licht:Lab_News"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#lls-scor-2012"
  },
  {
   "id": "starr-diet-immunity",
   "title": "Dietary regulation of cancer immunity",
   "group": "Cancer research and translational programs",
   "funders": [
    "Starr Cancer Consortium (The Starr Foundation)"
   ],
   "program": "Dietary regulation of cancer immunity — Thirteenth Starr Cancer Consortium Grant Competition",
   "programType": "Multi-institution consortium grant",
   "awardNumbers": [
    "I13-0052"
   ],
   "awardStart": null,
   "awardEnd": null,
   "awardPeriod": "Awarded in the consortium’s thirteenth grant competition, listed on the consortium’s site by December 2019.",
   "principalInvestigators": "Semir Beyaz (principal investigator, Cold Spring Harbor Laboratory); co-principal investigators Christopher E. Mason (Weill Cornell Medicine) and Kıvanç Birsoy (The Rockefeller University).",
   "meydanRole": "Co-investigator",
   "meydanParticipation": "2020–2021 (Dr. Meydan’s records).",
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This Starr Cancer Consortium project linked nutrition, immune responses, and cancer biology across Cold Spring Harbor Laboratory, Weill Cornell Medicine, and The Rockefeller University. As a co-investigator, Dr. Meydan contributed computational and multi-omic research expertise. Published studies he coauthored acknowledge support from this award.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "diets",
     "type": "paper",
     "title": "Diverse high-fat diets drive multi-omic reprogramming that persists after dietary reversal (preprint)",
     "year": "2026",
     "url": "https://doi.org/10.64898/2026.03.17.708620",
     "acknowledges": "I13-0052",
     "note": "bioRxiv preprint; Dr. Meydan is co-corresponding author, credited with data curation, formal analysis, software, visualization, supervision, and writing.",
     "archivedCopy": null
    },
    {
     "id": "setd2",
     "type": "paper",
     "title": "SETD2 haploinsufficiency enhances AICDA mutagenesis in B-cell lymphoma",
     "year": "2022",
     "url": "https://doi.org/10.1158/2159-8290.CD-21-1514",
     "acknowledges": "I13-0052",
     "note": "Coauthored B-cell lymphoma study.",
     "archivedCopy": null
    },
    {
     "id": "smc3",
     "type": "paper",
     "title": "Smc3 dosage regulates B-cell transit through germinal centers",
     "year": "2021",
     "url": "https://doi.org/10.1038/s41590-020-00827-8",
     "acknowledges": "I13-0052",
     "note": "Coauthored study of cohesin dosage in germinal-center B cells.",
     "archivedCopy": null
    },
    {
     "id": "telomeres",
     "type": "paper",
     "title": "Haplotype diversity and sequence heterogeneity of human telomeres",
     "year": "2021",
     "url": "https://doi.org/10.1101/gr.274639.120",
     "acknowledges": "I13-0052",
     "note": "Coauthored genome-assembly study of human telomeres.",
     "archivedCopy": null
    },
    {
     "id": "diets-explorer",
     "type": "resource",
     "title": "Diet–microbiome multi-omics explorer",
     "year": null,
     "url": "https://btierneyshiny.shinyapps.io/high-fat-diets-multi-omics/",
     "acknowledges": null,
     "note": "Interactive explorer for the diet multi-omics data, hosted by the study team.",
     "archivedCopy": "https://web.archive.org/web/20261031001050/https://btierneyshiny.shinyapps.io/high-fat-diets-multi-omics/"
    },
    {
     "id": "diets-code",
     "type": "resource",
     "title": "Diet study analysis code and metadata",
     "year": null,
     "url": "https://github.com/b-tierney/multi-omics-of-high-fat-diets/",
     "acknowledges": null,
     "note": "Analysis scripts and data manifests for the diet study, from the study team.",
     "archivedCopy": "https://web.archive.org/web/20261031001235/https://github.com/b-tierney/multi-omics-of-high-fat-diets/"
    },
    {
     "id": "diets-data",
     "type": "resource",
     "title": "Diet study multi-omics dataset",
     "year": null,
     "url": "https://figshare.com/projects/_b_Diverse_high-fat_diets_drive_multi-omic_reprogramming_that_persists_after_dietary_reversal_b_/270115",
     "acknowledges": null,
     "note": "Multi-omics dataset listed in the preprint’s data-availability statement.",
     "archivedCopy": "https://web.archive.org/web/20261031001414/https://figshare.com/projects/_b_Diverse_high-fat_diets_drive_multi-omic_reprogramming_that_persists_after_dietary_reversal_b_/270115"
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Thirteenth Starr Cancer Consortium Grant Competition",
     "publisher": "Starr Cancer Consortium",
     "url": "https://starrcancer.org/awarded-grants/thirteenth-competition",
     "documents": "The project, its principal investigator and co-principal investigators.",
     "archivedCopy": "https://web.archive.org/web/20250814145153/https://starrcancer.org/awarded-grants/thirteenth-competition"
    },
    {
     "title": "Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis (Cell Stem Cell, 2021)",
     "publisher": "Cell Stem Cell",
     "url": "https://doi.org/10.1016/j.stem.2021.08.007",
     "documents": "Research from the Beyaz laboratory supported by I13-0052.",
     "archivedCopy": null
    },
    {
     "title": "Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation (Nature Immunology, 2021)",
     "publisher": "Nature Immunology",
     "url": "https://doi.org/10.1038/s41590-020-00827-8",
     "documents": "A paper coauthored by Dr. Meydan that acknowledges Starr Cancer Consortium I13-0052.",
     "archivedCopy": null
    },
    {
     "title": "Haplotype diversity and sequence heterogeneity of human telomeres (Genome Research, 2021)",
     "publisher": "Genome Research",
     "url": "https://doi.org/10.1101/gr.274639.120",
     "documents": "A paper coauthored by Dr. Meydan that acknowledges STARR I13-0052.",
     "archivedCopy": null
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#starr-diet-immunity"
  },
  {
   "id": "ecog-acrin-ltsc",
   "title": "ECOG-ACRIN Integrated Leukemia Translational Science Center",
   "group": "Cancer research and translational programs",
   "funders": [
    "NIH / National Cancer Institute"
   ],
   "program": "ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)",
   "programType": "Cooperative agreement (UG1)",
   "awardNumbers": [
    "UG1CA233332"
   ],
   "awardStart": "2019-03-07",
   "awardEnd": "2026-02-28",
   "awardPeriod": "March 2019 – February 2026 (NIH RePORTER). The center was established in 2019.",
   "principalInvestigators": "Ross L. Levine and Omar Abdel-Wahab (contact PIs, Memorial Sloan Kettering Cancer Center), with Ari M. Melnick, Adolfo A. Ferrando and Sheng Cai.",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "The NCI-supported ECOG-ACRIN Leukemia Integrated Translational Science Center connects clinical leukemia studies with molecular profiling, biomarker research, and analytical resources. Dr. Meydan contributed computational expertise as key personnel in the associated collaborative translational research.",
   "notes": [],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "ECOG-ACRIN Integrated Leukemia Translational Science Center, UG1CA233332",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/11250227",
     "documents": "Award number, principal investigators, institution and project dates.",
     "archivedCopy": "https://web.archive.org/web/20261030164552/https://reporter.nih.gov/project-details/11250227"
    },
    {
     "title": "Leukemia Integrated Translational Science Center",
     "publisher": "ECOG-ACRIN Cancer Research Group",
     "url": "https://ecog-acrin.org/research-cores/leukemia-integrated-translational-science-center/",
     "documents": "The center’s purpose and establishment in 2019.",
     "archivedCopy": "https://web.archive.org/web/20261030160240/https://ecog-acrin.org/research-cores/leukemia-integrated-translational-science-center/"
    },
    {
     "title": "UG1CA233332 award detail",
     "publisher": "HHS TAGGS",
     "url": "https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=UG1CA233332&arg_ProgOfficeCode=110",
     "documents": "Award actions by fiscal year.",
     "archivedCopy": "https://web.archive.org/web/20261030160400/https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=UG1CA233332&arg_ProgOfficeCode=110"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#ecog-acrin-ltsc"
  },
  {
   "id": "utx-ucfdna-r01",
   "title": "Urinary cell-free DNA to monitor infection after kidney transplantation",
   "group": "Microbiome, infection, and spatial profiling",
   "funders": [
    "NIH / National Institute of Allergy and Infectious Diseases"
   ],
   "program": "Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation",
   "programType": "Research project grant (R01)",
   "awardNumbers": [
    "R01AI151059"
   ],
   "awardStart": "2020-03-10",
   "awardEnd": "2026-02-28",
   "awardPeriod": "March 2020 – February 2026, including a no-cost extension (NIH RePORTER).",
   "principalInvestigators": "Iwijn De Vlaminck (contact PI, Cornell University), Christopher E. Mason and Darshana Dadhania (Weill Cornell Medicine)",
   "meydanRole": "Key personnel",
   "meydanParticipation": "2020–2025 (Dr. Meydan’s records).",
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NIH-supported Cornell–Weill Cornell collaboration investigated metagenomic profiling of urinary cell-free DNA for infection monitoring after kidney transplantation. As key personnel, Dr. Meydan contributed computational and molecular-data expertise to research on noninvasive microbial diagnostics.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "ibs",
     "type": "paper",
     "title": "Improved gastrointestinal health for irritable bowel syndrome with metagenome-guided interventions",
     "year": "2020",
     "url": "https://doi.org/10.1093/pcmedi/pbaa013",
     "acknowledges": "R01AI151059",
     "note": "Co-first-authored study of metagenome-guided interventions in irritable bowel syndrome.",
     "archivedCopy": null
    },
    {
     "id": "il1b-il6",
     "type": "paper",
     "title": "Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19",
     "year": "2021",
     "url": "https://doi.org/10.1016/j.isci.2020.101896",
     "acknowledges": "R01AI151059",
     "note": "Coauthored study of IL-1β and IL-6 transcriptional response modules in COVID-19.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Metagenomic profiling of urinary cell-free DNA…, R01AI151059",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/10796842",
     "documents": "Award number, principal investigators, institution and project dates.",
     "archivedCopy": "https://web.archive.org/web/20261030164658/https://reporter.nih.gov/project-details/10796842"
    },
    {
     "title": "Intercampus team to develop post-transplant UTI diagnosis",
     "publisher": "Cornell Chronicle",
     "url": "https://news.cornell.edu/stories/2020/10/intercampus-team-develop-post-transplant-uti-diagnosis",
     "documents": "The 2020 award announcement and its investigators.",
     "archivedCopy": "https://web.archive.org/web/20261030155059/https://news.cornell.edu/stories/2020/10/intercampus-team-develop-post-transplant-uti-diagnosis"
    },
    {
     "title": "Intercampus collaboration awarded grant to develop method for diagnosing urinary tract infections",
     "publisher": "Weill Cornell Medicine Research",
     "url": "https://research.weill.cornell.edu/about-us/news-updates/intercampus-collaboration-awarded-grant-develop-method-diagnosing-urinary",
     "documents": "Weill Cornell announcement of the award.",
     "archivedCopy": "https://web.archive.org/web/20201026163648/https://research.weill.cornell.edu/about-us/news-updates/intercampus-collaboration-awarded-grant-develop-method-diagnosing-urinary"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#utx-ucfdna-r01"
  },
  {
   "id": "crc-spatial-atlas",
   "title": "A spatially resolved molecular atlas of colorectal cancer",
   "group": "Microbiome, infection, and spatial profiling",
   "funders": [
    "Gastro-Intestinal Research Foundation (CA CURE)"
   ],
   "program": "Colorectal Cancer (CRC) Cellular Heterogeneity, Metastasis, and a Spatially-resolved Molecular Atlas for the Colon",
   "programType": "Foundation research grant",
   "awardNumbers": [],
   "awardStart": "2022",
   "awardEnd": "2024",
   "awardPeriod": "2022–2024 (Dr. Meydan’s participation period).",
   "principalInvestigators": "Christopher E. Mason (principal investigator)",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This Gastro-Intestinal Research Foundation project applied spatially resolved RNA and protein profiling to colorectal cancer heterogeneity, tissue organization, and metastasis. Dr. Meydan contributed computational expertise as key personnel, extending his spatial-omics research into solid-tumor biology.",
   "notes": [],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "CA CURE research grants",
     "publisher": "Gastro-Intestinal Research Foundation",
     "url": "https://giresearchfoundation.org/research-grants/ca-cure-main/",
     "documents": "The funded project and its lead investigator.",
     "archivedCopy": "https://web.archive.org/web/20261030154823/https://giresearchfoundation.org/research-grants/ca-cure-main/"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#crc-spatial-atlas"
  },
  {
   "id": "nasa-heart-brain",
   "title": "Spatiotemporal mapping of spaceflight effects on heart and brain",
   "group": "Spaceflight and interdisciplinary genomics",
   "funders": [
    "NASA Space Biology"
   ],
   "program": "Spatiotemporal Mapping of the Impact of Spaceflight on the Heart and Brain",
   "programType": "NASA research grant (ground study)",
   "awardNumbers": [
    "80NSSC22K0254"
   ],
   "awardStart": "2021-12-01",
   "awardEnd": "2024-11-30",
   "awardPeriod": "December 2021 – November 2024 (NASA Task Book).",
   "principalInvestigators": "Christopher E. Mason (principal investigator); co-investigators Sylvain Costes and Jonathan Galazka (NASA Ames) and Stefania Giacomello (KTH)",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NASA program investigated the molecular effects of spaceflight in heart and brain using spatial transcriptomics, single-cell profiling, and integrative analysis. As key personnel, Dr. Meydan contributed computational research expertise to the study of tissue- and cell-specific responses.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "skin",
     "type": "paper",
     "title": "Spatial multi-omics of human skin reveals KRAS and inflammatory responses to spaceflight",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41467-024-48625-2",
     "acknowledges": "80NSSC22K0254",
     "note": "Coauthored spatial multi-omics study of skin samples from spaceflight.",
     "archivedCopy": null
    },
    {
     "id": "i4-multiome",
     "type": "paper",
     "title": "Single-cell multi-ome and immune profiles of the Inspiration4 crew",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41467-024-49211-2",
     "acknowledges": "80NSSC22K0254",
     "note": "Coauthored single-cell multi-ome study of the Inspiration4 crew.",
     "archivedCopy": null
    },
    {
     "id": "soma",
     "type": "paper",
     "title": "The Space Omics and Medical Atlas (SOMA) and international astronaut biobank",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41586-024-07639-y",
     "acknowledges": "80NSSC22K0254",
     "note": "Dr. Meydan is co-corresponding author.",
     "archivedCopy": null
    },
    {
     "id": "soma-browser",
     "type": "resource",
     "title": "SOMA Browser",
     "year": null,
     "url": "https://soma.weill.cornell.edu/apps/SOMA_Browser/",
     "acknowledges": null,
     "note": "Dr. Meydan wrote the browser’s code and visualizations; the site acknowledges this award.",
     "archivedCopy": "https://web.archive.org/web/20261030155826/https://soma.weill.cornell.edu/apps/SOMA_Browser/"
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Task Book project record, 80NSSC22K0254",
     "publisher": "NASA Task Book",
     "url": "https://taskbook.nasaprs.com/tbp/index.cfm?TASKID=A3C9A48E20ACB81803EBCCBDEF6C8E56&action=public_query_taskbook_content",
     "documents": "Project, principal investigator and co-investigators, dates, scientific plan, and a bibliography that includes papers coauthored by Dr. Meydan.",
     "archivedCopy": "https://web.archive.org/web/20261030154940/https://taskbook.nasaprs.com/tbp/index.cfm?TASKID=A3C9A48E20ACB81803EBCCBDEF6C8E56&action=public_query_taskbook_content"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#nasa-heart-brain"
  },
  {
   "id": "nasa-noncoding-epigenome",
   "title": "The noncoding genome and epigenome in astronauts",
   "group": "Spaceflight and interdisciplinary genomics",
   "funders": [
    "NASA Human Research Program"
   ],
   "program": "An Integrated Framework for Characterization of the Noncoding Genome and Epigenome in Astronauts",
   "programType": "NASA research grant",
   "awardNumbers": [
    "NNX17AB26G"
   ],
   "awardStart": "2016-10-26",
   "awardEnd": "2018-10-25",
   "awardPeriod": "October 26, 2016 – October 25, 2018 (NASA Task Book).",
   "principalInvestigators": "Christopher E. Mason (principal investigator); co-investigator Michael Snyder (Stanford University)",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NASA Human Research Program award supported analysis of noncoding genomic and epigenomic changes during human spaceflight. Dr. Meydan contributed computational genomics expertise as key personnel, connecting epigenome analysis with longitudinal research on astronaut molecular responses.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "skin",
     "type": "paper",
     "title": "Spatial multi-omics of human skin reveals KRAS and inflammatory responses to spaceflight",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41467-024-48625-2",
     "acknowledges": "NNX17AB26G",
     "note": "Coauthored spatial multi-omics study of skin samples from spaceflight.",
     "archivedCopy": null
    },
    {
     "id": "i4-multiome",
     "type": "paper",
     "title": "Single-cell multi-ome and immune profiles of the Inspiration4 crew",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41467-024-49211-2",
     "acknowledges": "NNX17AB26G",
     "note": "Coauthored single-cell multi-ome study of the Inspiration4 crew.",
     "archivedCopy": null
    },
    {
     "id": "soma",
     "type": "paper",
     "title": "The Space Omics and Medical Atlas (SOMA) and international astronaut biobank",
     "year": "2024",
     "url": "https://doi.org/10.1038/s41586-024-07639-y",
     "acknowledges": "NNX17AB26G",
     "note": "Dr. Meydan is co-corresponding author.",
     "archivedCopy": null
    },
    {
     "id": "soma-browser",
     "type": "resource",
     "title": "SOMA Browser",
     "year": null,
     "url": "https://soma.weill.cornell.edu/apps/SOMA_Browser/",
     "acknowledges": null,
     "note": "Dr. Meydan wrote the browser’s code and visualizations; the site lists NNX17AB26G among its support.",
     "archivedCopy": "https://web.archive.org/web/20261030155826/https://soma.weill.cornell.edu/apps/SOMA_Browser/"
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Task Book project record, NNX17AB26G",
     "publisher": "NASA Task Book",
     "url": "https://taskbook.nasaprs.com/tbp/index.cfm?action=public_query_taskbook_content&TASKID=2EA033ACB9AEEA8E580C288D53E257E4",
     "documents": "Project title, principal investigator and co-investigator, grant number, start and end dates (NASA Human Research Program).",
     "archivedCopy": "https://web.archive.org/web/20261030164738/https://taskbook.nasaprs.com/tbp/index.cfm?action=public_query_taskbook_content&TASKID=2EA033ACB9AEEA8E580C288D53E257E4"
    },
    {
     "title": "SOMA Browser — funding acknowledgments",
     "publisher": "Weill Cornell Medicine",
     "url": "https://soma.weill.cornell.edu/apps/SOMA_Browser/",
     "documents": "Acknowledges NASA NNX17AB26G among the grants supporting the SOMA data resource, whose code and visualizations are by Dr. Meydan.",
     "archivedCopy": "https://web.archive.org/web/20261030155826/https://soma.weill.cornell.edu/apps/SOMA_Browser/"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#nasa-noncoding-epigenome"
  },
  {
   "id": "ninds-epigenome-r01",
   "title": "Epigenome interactions in complex neurogenetic disorders",
   "group": "Spaceflight and interdisciplinary genomics",
   "funders": [
    "NIH / National Institute of Neurological Disorders and Stroke"
   ],
   "program": "Epigenome Interactions in Complex Neurogenetic Disorders",
   "programType": "Research project grant (R01)",
   "awardNumbers": [
    "R01NS076465"
   ],
   "awardStart": "2011-09-01",
   "awardEnd": "2017-05-31",
   "awardPeriod": "September 2011 – May 2017 (NIH RePORTER).",
   "principalInvestigators": "M. Elizabeth Ross (contact PI) and Christopher E. Mason, Weill Cornell Medicine",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "This NINDS-funded project studied interactions between genetic and epigenetic variation in complex neurogenetic disorders. Dr. Meydan contributed genomic analysis and computational research expertise as key personnel, reflecting an earlier phase of his work integrating heterogeneous molecular data.",
   "notes": [],
   "selectedOutputs": [
    {
     "id": "idh2-tet2",
     "type": "paper",
     "title": "Combination targeted therapy in IDH2- and TET2-mutant AML",
     "year": "2017",
     "url": "https://doi.org/10.1158/2159-8290.CD-16-1049",
     "acknowledges": "R01NS076465",
     "note": "Co-first-authored Cancer Discovery study of combination targeted therapy in IDH2- and TET2-mutant AML.",
     "archivedCopy": null
    },
    {
     "id": "telomeres",
     "type": "paper",
     "title": "Haplotype diversity and sequence heterogeneity of human telomeres",
     "year": "2021",
     "url": "https://doi.org/10.1101/gr.274639.120",
     "acknowledges": "R01NS076465",
     "note": "Coauthored genome-assembly study of human telomeres.",
     "archivedCopy": null
    }
   ],
   "components": [],
   "sources": [
    {
     "title": "Epigenome Interactions in Complex Neurogenetic Disorders, R01NS076465",
     "publisher": "NIH RePORTER",
     "url": "https://reporter.nih.gov/project-details/8860253",
     "documents": "Award number, principal investigators and project dates.",
     "archivedCopy": "https://web.archive.org/web/20261030164915/https://reporter.nih.gov/project-details/8860253"
    },
    {
     "title": "Grant record and project abstract",
     "publisher": "OpenAlex",
     "url": "https://openalex.org/awards/G7627010251",
     "documents": "Indexed award record and abstract.",
     "archivedCopy": "https://web.archive.org/web/20261030161232/https://openalex.org/awards/G7627010251"
    },
    {
     "title": "Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome (Nature Methods, 2015)",
     "publisher": "Nature Methods",
     "url": "https://www.nature.com/articles/nmeth.3453",
     "documents": "A paper coauthored by Dr. Meydan that acknowledges NS076465 (to C.E. Mason).",
     "archivedCopy": "https://web.archive.org/web/20261030161309/https://www.nature.com/articles/nmeth.3453?error=cookies_not_supported&code=984af987-36c9-4ad5-9f70-57acaaebeda0"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#ninds-epigenome-r01"
  },
  {
   "id": "jade-fp7",
   "title": "JADE: transnational research clusters for independent living of older adults",
   "group": "Earlier international research programs",
   "funders": [
    "European Commission, Seventh Framework Programme (Regions of Knowledge)"
   ],
   "program": "JADE — Joining innovative Approaches for the integration and Development of transnational knowledge of clusters policies related to independent of Elderly",
   "programType": "Coordination and support action",
   "awardNumbers": [
    "Grant agreement 266422"
   ],
   "awardStart": "2011-02",
   "awardEnd": "2014-01",
   "awardPeriod": "February 2011 – January 2014 (CORDIS).",
   "principalInvestigators": "Coordinated by Sviluppo Europa Marche (Italy), with 41 participating organizations including Sabancı University (Türkiye)",
   "meydanRole": "Key personnel",
   "meydanParticipation": null,
   "roleSource": "Dr. Meydan’s professional funding records.",
   "roleListedInIndependentRecord": false,
   "summary": "JADE was a European Commission-supported collaboration on research-driven innovation for independent living among older adults. Dr. Meydan served as key personnel in the Sabancı University-associated work during an earlier stage of his research career.",
   "notes": [],
   "selectedOutputs": [],
   "components": [],
   "sources": [
    {
     "title": "JADE, grant agreement 266422",
     "publisher": "European Commission CORDIS",
     "url": "https://cordis.europa.eu/project/id/266422",
     "documents": "Project, programme, dates and participating organizations.",
     "archivedCopy": "https://web.archive.org/web/20261030161815/https://cordis.europa.eu/project/id/266422"
    }
   ],
   "url": "https://www.cemmeydan.com/research/funding/#jade-fp7"
  }
 ]
}